Hormone replacement therapy (HRT)
Also called HRT, Menopause hormone therapy
Treatment of menopause and perimenopause symptoms with estrogen, usually with progesterone where the patient has an intact uterus, or with non-hormonal alternatives.
HRT is typically estradiol delivered as a pill, patch, cream or vaginal gel, with progesterone added where clinically indicated. Non-hormonal options exist for patients with contraindications to estrogen.
The clinical rhythm is symptom-led rather than lab-gated, which makes it operationally lighter than testosterone therapy: asynchronous review with quarterly follow-up is the norm.
The operational rule that catches operators out is that any medication or delivery-form change restarts the review clock, triggering a refill intake weeks later rather than at the next quarterly date.
Menopause care is a multi-year relationship, so retention infrastructure matters more than checkout conversion. Estradiol and progesterone are not controlled substances, so the state map is unconstrained.
Hormone replacement therapy (HRT), in practice
Not as a universal gate. Labs are ordered on clinical indication rather than for every patient, which is a real operational difference from testosterone therapy where baseline and quarterly panels gate the fills.